Skip to main content
A

ALLOX

ALLOX utilizes systematic mutagenesis, high-throughput phenotyping, and biophysical modeling to identify allosteric switches in proteins, enabling the rapid development of novel therapeutics for human diseases. By harnessing genetics and AI, the company addresses the challenge of predicting and engineering protein functions, aiming to transform drug discovery and biotechnology.

Barcelona, SpainFounded 2023111K+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Traditional drug discovery methods often struggle to target allosteric sites on proteins, which are crucial for regulating protein function and can be difficult to identify and engineer. Predicting and manipulating protein functions remains a significant challenge, hindering the development of novel therapeutics.

Solution

ALLOX leverages systematic mutagenesis, high-throughput phenotyping, and biophysical modeling, enhanced by AI, to identify and exploit allosteric switches in proteins. The company's technology uncovers the biophysical parameters governing protein function, enabling the rational design of novel therapeutics. By mapping allosteric sites and understanding their impact on protein behavior, ALLOX facilitates the development of drugs that can modulate protein activity with greater precision and efficacy. This approach addresses the limitations of traditional methods by providing a comprehensive platform for allosteric drug discovery.

Target Audience

The primary target audience includes pharmaceutical and biotechnology companies seeking innovative approaches to drug discovery, particularly for targets where traditional methods have proven ineffective.

Features

  • Systematic mutagenesis to generate comprehensive protein variant libraries.
  • High-throughput phenotyping to assess the functional impact of mutations.
  • Biophysical modeling to understand the underlying mechanisms of allosteric regulation.
  • AI-driven analysis to predict and engineer protein functions.
  • Identification of novel allosteric sites for drug targeting.
  • Development of therapeutics that modulate protein activity with high precision.
This profile is AI-generated and may contain inaccuracies.